ATE290875T1 - Extrakte des pilzes guignardia sp., deren verwendung in pharmazeutischen verbindungen; neu isolierte verbindung aus guignardia sp. pilzextrakten und deren verwendung in pharmazeutischen präparaten - Google Patents

Extrakte des pilzes guignardia sp., deren verwendung in pharmazeutischen verbindungen; neu isolierte verbindung aus guignardia sp. pilzextrakten und deren verwendung in pharmazeutischen präparaten

Info

Publication number
ATE290875T1
ATE290875T1 AT01959996T AT01959996T ATE290875T1 AT E290875 T1 ATE290875 T1 AT E290875T1 AT 01959996 T AT01959996 T AT 01959996T AT 01959996 T AT01959996 T AT 01959996T AT E290875 T1 ATE290875 T1 AT E290875T1
Authority
AT
Austria
Prior art keywords
guignardia
extracts
mushroom
pharmaceutical
connection made
Prior art date
Application number
AT01959996T
Other languages
English (en)
Inventor
Rodrigues Heerklotz K Ferreira
Joerg Arno Heerklotz
Christa Werner
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR0003972-1A external-priority patent/BR0003972A/pt
Priority claimed from BR0003971-3A external-priority patent/BR0003971A/pt
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Application granted granted Critical
Publication of ATE290875T1 publication Critical patent/ATE290875T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mushroom Cultivation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01959996T 2000-09-01 2001-08-29 Extrakte des pilzes guignardia sp., deren verwendung in pharmazeutischen verbindungen; neu isolierte verbindung aus guignardia sp. pilzextrakten und deren verwendung in pharmazeutischen präparaten ATE290875T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR0003972-1A BR0003972A (pt) 2000-09-01 2000-09-01 Novo composto isolado do extrato do fungo guignardia sp. e seu uso em composições medicamentosas
BR0003971-3A BR0003971A (pt) 2000-09-01 2000-09-01 Extratos do fungo guignardia sp. e seus usos em composições medicamentosas
PCT/BR2001/000110 WO2002017937A1 (en) 2000-09-01 2001-08-29 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE290875T1 true ATE290875T1 (de) 2005-04-15

Family

ID=25663412

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01959996T ATE290875T1 (de) 2000-09-01 2001-08-29 Extrakte des pilzes guignardia sp., deren verwendung in pharmazeutischen verbindungen; neu isolierte verbindung aus guignardia sp. pilzextrakten und deren verwendung in pharmazeutischen präparaten

Country Status (7)

Country Link
US (2) US6544524B2 (de)
EP (1) EP1318824B1 (de)
AT (1) ATE290875T1 (de)
AU (1) AU2001281613A1 (de)
DE (1) DE60109465D1 (de)
IT (1) ITMI20011837A1 (de)
WO (1) WO2002017937A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6788793B2 (en) 2002-06-04 2004-09-07 Motorola, Inc. Speaker system for an electronic device
US20050196594A1 (en) * 2004-03-02 2005-09-08 Illinois Tool Works, Inc. In-mold label composition and process
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US20090017140A1 (en) * 2007-07-09 2009-01-15 Peter Koepke Maytenus abenfolia extract and methods of extracting and using such extract
US20090035395A1 (en) * 2007-08-01 2009-02-05 Peter Koepke Spondias mombin l. extract and methods of extracting and using such extract
US7879369B2 (en) * 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
ES2565516B1 (es) * 2014-09-01 2017-01-17 Consejo Superior De Investigaciones Científicas (Csic) Productos biocidas y su uso para el control de fitopatógenos yorganismos plaga que afectan a plantas
ES2610186B1 (es) 2015-10-23 2018-09-06 Consejo Superior De Investigaciones Cientificas Biocidas naturales de amplio espectro procedentes del hongo endófito stemphylium solani
CN115011487B (zh) * 2022-05-12 2023-08-18 宁波大学 一种海绵共附生真菌及其在制备杂萜类化合物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891506A (en) 1967-06-21 1975-06-24 Kowa Co Antibiotic substance and process for its preparation
US5919746A (en) 1995-03-30 1999-07-06 Novo Nordisk A/S Alkaline lipolytic enzyme
EP0817838B1 (de) * 1995-03-30 2003-06-11 Novozymes A/S Alkalisches lypolitsches enzym
US5888757A (en) * 1996-05-03 1999-03-30 Millennium Pharmaceuticals, Inc. Cell wall assay
US6303302B1 (en) * 1997-11-19 2001-10-16 The Whitehead Institute For Biomedical Research Regulation of fungal gene expression

Also Published As

Publication number Publication date
US6544524B2 (en) 2003-04-08
ITMI20011837A1 (it) 2003-03-03
ITMI20011837A0 (it) 2001-08-31
AU2001281613A1 (en) 2002-03-13
EP1318824A1 (de) 2003-06-18
US20030165532A1 (en) 2003-09-04
US20020048589A1 (en) 2002-04-25
DE60109465D1 (de) 2005-04-21
WO2002017937A1 (en) 2002-03-07
EP1318824B1 (de) 2005-03-16

Similar Documents

Publication Publication Date Title
MXPA02012271A (es) Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor.
MXPA03007942A (es) Preparaciones de insulina exentas de zinc y con bajo contenido de zinc, que tienen una estabilidad mejorada.
WO2003105800A3 (de) Filmförmige mucoadhäsive darreichungsformen zur verabreichung von cannabis-wirkstoffen
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
NO20034660L (no) Spiropyrazolforbindelser, farmasoytiske preparater som omfatter en slik forbindelse, og anvendelse av forbindelsene for fremstilling av farmasoytiske preparater
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
EA200300050A1 (ru) Гликопептидфосфонатные производные
UA96449C2 (en) Stable laquinimod preparations
BR0110961A (pt) Derivados de triazol
EA200200072A1 (ru) Пресервированные фармацевтические составы
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
GB2363985B (en) Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
CY1119188T1 (el) Αντιμικροβιακα συντηρητικα για την επιτευξη φαρμακοτεχνικης μορφης πολλαπλης δοσης χρησιμοποιωντας βητα-κυκλοεξτρινες για υγρες μορφες δοσολογιας
ATE290875T1 (de) Extrakte des pilzes guignardia sp., deren verwendung in pharmazeutischen verbindungen; neu isolierte verbindung aus guignardia sp. pilzextrakten und deren verwendung in pharmazeutischen präparaten
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
HK1039273A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
MXPA04000874A (es) Composicion funguicida y uso de la composicion para controlar las enfermedades de las plantas.
BRPI0317188A2 (pt) Novo derivado de 2,4-diamino-1,3,5-triazina
TR200301650T4 (tr) Ziraat ve bahçecilikte kullanım için okzim O-eter bileşikleri ve fungusitler
MX2007008585A (es) Compuestos peptidicos.
MY130373A (en) Linear basic compounds having nk-2 antagonist activity and formulations thereof
BR0207534A (pt) Composto de triazol ou um sal deste farmacologicamente eficaz, composição farmacêutica e uso de um composto
BR0116205A (pt) 2-piridonas antimicrobianas, suas composições e usos
ATE259638T1 (de) Nicht-festes topisch anzuwendendes arzneimittel enthaltend glyzerol und alchemilla vulgaris extrakt
DE60013111D1 (de) Mundpflegezusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties